Immunotherapies strengthen the body's own anticancer defenses in a highly targeted manner. In therapies using so-called CAR T ...

T-cell therapy has transformed outcomes in several blood cancers, but its success is far from uniform. According to Kerry ...

Therapy planning shifted from intended autologous transplant to CAR-T; detailed counseling helped align expectations and ...

After day 30, patients ≥65 years had greater transient physical-function worsening than younger patients, but age-related ...

환자 자신의 면역세포를 재설계해 비정상 세포를 제거하는 면역치료법인 '키메라항원수용체-T(CAR-T)' 치료는 대부분 CAR-T세포를 실험실에서 만들어 체내에 주입하는 복잡한 과정을 거친다. CAR-T세포를 몸 속에서 직접 ...

At 25, Michael Walters had already endured unsuccessful lymphoma treatments in New Zealand. A Melbourne hospital quoted up to ...

Immunotherapies such as CAR T-cell therapy are used primarily to treat cancer. In the future, these patient-specific ...

Amandeep Godara, MBBS, explained that rural patients with multiple myeloma face various barriers to immunotherapies that may ...

Johnson said he hopes the cell therapy will eventually produce “robust” and “long-lived” effects that extend patients’ life ...

Doctors at the University of Washington and Fred Hutch Cancer Center have better characterized an emerging complication of chimeric antigen receptor (CAR) T-cell therapy. A recent paper in Movement ...

CAR T-cell therapy is a personalized treatment that uses a patient’s own immune cells to fight cancer, making it effective but unsuitable for mass production, which increases the cost. The complex ...

Novartis suspended multiple studies of a CAR T candidate after three patients who received the therapy suffered fatal cases ...